Avadel Pharmaceuticals
Price & Volume
Stats
See moreOpen | $12.86 |
Previous Close | $12.79 |
Day Range | $12.85-$13.62 |
52W Range | $6.38-$16.66 |
Market Cap | $1.2B |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $221M |
Revenue Growth (YoY) | 64.2% |
Gross Profit (12 Mos) | $198.1M |
Diluted EPS | -$0.26 |
News
See moreYahoo Finance • 5 days ago
Avadel raises 2025 revenue guidance to $275M as LUMRYZ patient base grows 63% year-over-year
Yahoo Finance • 5 days ago
Avadel Pharmaceuticals (NASDAQ:AVDL) Surges 6.3% in Pre-Market as Q2 Earnings Crush Estimates on Strong LUMRYZ Performance
Yahoo Finance • 12 days ago
Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2025 Financial Results on August 7
Yahoo Finance • 22 days ago
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Mr. Gregory J. Divis Jr. |
CFO | Mr. Thomas S. McHugh |
Address | 10 Earlsfort Terrace, Dublin, Ireland, D02 T380 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 188 |
